Coverart for item
The Resource Intellikine : build-to-sell in biotech, Larry Lasky

Intellikine : build-to-sell in biotech, Larry Lasky

Label
Intellikine : build-to-sell in biotech
Title
Intellikine
Title remainder
build-to-sell in biotech
Statement of responsibility
Larry Lasky
Creator
Author
Subject
Genre
Language
eng
Summary
The Intellikine case study provides an example of a biotech company where its management team, founders, and investors sold the company at a relatively early stage of the company's development. In early 2012, Troy Wilson, the CEO of Intellikine sold the company to Millennium: The Takeda Oncology Company, Takeda's business unit responsible for global oncology, strategy, and development. The deal was for as much as $310 million (Millennium would pay $190 million upfront, with an additional $120 million dependent on clinical development milestones). By 2011, the Intellikine team had advanced three programs into human clinical testing. The key question for students is whether Wilson and his team sold the company too early or not. Various perspectives and the company strategy and execution are provided in the case study to allow students to have a fruitful discussion on each side of the argument
Member of
Cataloging source
CaToSAGE
http://library.link/vocab/creatorName
Lasky, Larry
Dewey number
658.16
Index
no index present
LC call number
HD2746.5
LC item number
.L37 2017
Literary form
non fiction
Nature of contents
dictionaries
Series statement
SAGE Knowledge. Cases
http://library.link/vocab/subjectName
  • Intellikine
  • Consolidation and merger of corporations
  • Business planning
  • Biotechnology industries
Target audience
specialized
Label
Intellikine : build-to-sell in biotech, Larry Lasky
Instantiates
Publication
Note
  • Originally published in Lasky, L. (2013). Intellikine: Build-to-sell in biotech. The Berkeley-Haas Case Series. University of California, Berkeley. Haas School of Business
  • 2Teacher Notes for Sage Business Cases are available for academic staff. Contact the Liaison Librarian for Business and Management for details3
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Control code
SAGE000000686
Extent
1 online resource.
Form of item
online
Isbn
9781526409355
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Specific material designation
remote
Label
Intellikine : build-to-sell in biotech, Larry Lasky
Publication
Note
  • Originally published in Lasky, L. (2013). Intellikine: Build-to-sell in biotech. The Berkeley-Haas Case Series. University of California, Berkeley. Haas School of Business
  • 2Teacher Notes for Sage Business Cases are available for academic staff. Contact the Liaison Librarian for Business and Management for details3
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Control code
SAGE000000686
Extent
1 online resource.
Form of item
online
Isbn
9781526409355
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Specific material designation
remote

Library Locations

Processing Feedback ...